Recon: Emergent execs to testify before house panel; ACIP weighs Pfizer vaccine in adolescents

• Pfizer COVID-19 vaccine works for adolescents, CDC panel told (Reuters)
• Pelosi drug price plan threatened by centrist defections (Politico) (STAT)
• Illumina CEO insists GRAIL merger will be good for competition, and ultimately, patients (STAT)
• AbbVie Slapped With Suit From Would-Be Humira Rival (Law360) (Fierce)
• Sanofi is accused of ‘widespread destruction’ of company e-mails tied to Zantac recall (STAT) (Fierce)
• States won't get Johnson & Johnson vaccines next week (Politico)
• CDC Chief Defends Pandemic Guidance as Impatience Mounts (NYTimes)
• The leaders of Emergent, whose factory spoiled vaccine doses, will testify before a US House panel. (NYTimes)

• More data needed before COVID-19 vaccine booster call - EU regulators (Reuters)
• How can we stop the next pandemic? Here's what a WHO panel recommends (Reuters 1, 2) (NYTimes)
• Australia taps Moderna for 25 million COVID-19 shots in vaccination ramp up (Reuters)
• Samsung BioLogics, Pfizer deny report on COVID-19 vaccine production in S.Korea (Reuters)
• Pfizer asks UK regulator to approve Covid vaccine for use in 12 to 15-year-olds (The Telegraph)
• Pfizer to seek COVID-19 vaccine approval in Mexico for children aged 12-15 (Reuters)
• Brazil buys 100 million more doses of Pfizer's COVID-19 vaccine (Reuters)

• Scientists probe impact of Indian Covid variant on vaccine efficacy (FT)
• Bahrain authorizes emergency use of one-shot Sputnik-Light COVID-19 vaccine (Reuters)
• U.S. official says Covid booster shots will also be free to the public (CNBC)

• Ginkgo plans a $17.5 billion merger with SPAC that took DraftKings public (STAT)
• Dana-Farber receives $50 million gift to study pancreatic cancer (STAT)
• Pandemic Urgencies Highlight Constraints in Manufacturing Change Regulatory Paradigm and Where Adjustments Are Needed (IPQ)
• Astellas’ Xtandi bags additional MHRA approval in prostate cancer (PharmaTimes)
• NICE rejects Pfizer’s rare heart disease treatment Vyndaqel (PharmaTimes)
• A closer look at the FDA’s more than 700 pandemic-related record requests to replace onsite inspections (Endpoints)
• Alexion co-founder Stephen Squinto is back in the game as CEO, this time for a small gene therapy player (Endpoints)
• George Golumbeski signs on at a European specialist VC firm with $265M to bet on genetic diseases (Endpoints)
• Biogen pushes in a fresh stack of chips and starts prepping a global R&D game plan after watching the cards turn on early thrombolytic data (Endpoints)
• Can a rare immune cell offer the key to slowing down senescence? A Bay Area startup looks to find out (Endpoints)
• Luisa Salter-Cid joins longtime Bristol Myers collaborator Paul Biondi at Flagship's new drug brewery (Endpoints)
• With backing from Bayer, a London firm will pitch its 'hospitals at home' concept for decentralized trials (Endpoints)
• Perceptive Advisors, Xontogeny bring the band back and then some with a $515M second fund sniffing out lead compounds (Endpoints)
• Lederle Laboratories et al.; Withdrawal of Approval of 12 Abbreviated New Drug Applications (FDA)

• Commission Calls For Notified Body Applicants As It Recognizes EU IVD Industry In Some Trouble (MedtechInsight)
• Bose gets into hearing aid business with new FDA-cleared SoundControl hearing aids (The Verge)
• The growing liquid biopsy field sees a unicorn entrant as Caris pulls in $830M megaround (Endpoints)
• Medtronic, Inc. Recalls Instructions for Use and Patient Manual for HeartWare HVAD System to Update Information about Carrying Case, Driveline Cover, and Controller Power-Up Issues (FDA)
• Whiterabbit emerges from stealth with FDA clearance for AI breast cancer screening tool (mobihealthnews)
• FDA eSTAR Update: 51 Submissions, No Manufacturer Complaints (MedtechInsight)
• Diabetes tech companies continue 2020's success with Q1 growth. Investors seem unimpressed (MedtechDive)
• Top Dems Mount Pressure On Becerra To Reverse COVID-19 LDT Policy Stopping FDA Oversight (MedtechInsight)

• Antitrust Division and Fellow Members of the Multilateral Pharmaceutical Merger Task Force Seek Public Input (DoJ)
• Study Coordinator Charged in Scheme to Falsify Clinical Trial Data (DOJ)
• Senate Confirms Andrea Palm As HHS Deputy Secretary (Law360)
• North Carolina Woman Arrested for Selling Unapproved Remedies for Covid-19 (FDA)
• Insulin Pump Maker Says Roche Sneaked Into Market (Law360)
• Walmart Wants 5th Circ. To Revive Opioid Suit Against Feds (Law360)
• Texas Pharma Co. Settles Opioid Whistleblower Suit For $2.8M (Law360)
• Elizabeth Holmes' Mystique Unlikely To Survive Looming Trial (Law360)